MRM3
Basic information
Region (hg38): 17:782353-792509
Previous symbols: [ "RNMTL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 4 | 0 | 0 |
Variants in MRM3
This is a list of pathogenic ClinVar variants found in the MRM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-782535-G-C | not specified | Uncertain significance (Sep 27, 2021) | ||
17-791665-G-T | not specified | Uncertain significance (Jun 21, 2021) | ||
17-791855-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
17-791956-C-T | not specified | Uncertain significance (Sep 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRM3 | protein_coding | protein_coding | ENST00000304478 | 4 | 10237 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.54e-10 | 0.123 | 125674 | 0 | 74 | 125748 | 0.000294 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.273 | 266 | 254 | 1.05 | 0.0000140 | 2728 |
Missense in Polyphen | 101 | 102.07 | 0.98953 | 1061 | ||
Synonymous | -0.648 | 118 | 109 | 1.08 | 0.00000654 | 868 |
Loss of Function | 0.301 | 15 | 16.3 | 0.919 | 8.03e-7 | 173 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000540 | 0.000539 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000416 | 0.000416 |
European (Non-Finnish) | 0.000335 | 0.000334 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: S-adenosyl-L-methionine-dependent 2'-O-ribose methyltransferase that catalyzes the formation of 2'-O- methylguanosine at position 1370 (Gm1370) in the 16S mitochondrial large subunit ribosomal RNA (mtLSU rRNA), a conserved modification in the peptidyl transferase domain of the mtLSU rRNA. {ECO:0000269|PubMed:24036117, ECO:0000269|PubMed:25009282, ECO:0000269|PubMed:25074936}.;
- Pathway
- rRNA processing;rRNA modification in the mitochondrion;Metabolism of RNA;rRNA processing in the mitochondrion
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.36
Haploinsufficiency Scores
- pHI
- 0.0876
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.464
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Mrm3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- rRNA 2'-O-methylation
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;protein binding;rRNA (guanosine-2'-O-)-methyltransferase activity